Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects

NCT ID: NCT05581680

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

720 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-12

Study Completion Date

2028-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The facial palsy is a frequent disease with a lot of etiologies. It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. Thanks to Motion Capture and Electromyography, a quantification of the facial mimicry is now possible with a great precision. In addition with the quantification of the facial mimicry, eye-tracking, wich is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular, will be used to evaluate the visio of the patients on their pathology in function of the movement quantification measured with MoCap and Electromyography. The aim of this research is to measure in a combined way the action potentials by sEMG and the amplitudes of displacement of the markers in motion capture, for movements determined in a population of patients presenting a facial pathology, in order to compare them with reference values obtained in healthy subjects. In a second step, the aim will be to study if there is a link between the way the patient looks at his pathology and the results of his management (treatment, rehabilitation) which will be quantitatively evaluated thanks to MoCap and sEMG.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Electromyography Eye-tracking Facial Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with facial palsy

Group Type EXPERIMENTAL

dental impressions

Intervention Type OTHER

dental impressions

Simultaneous MoCap and EMG acquisition

Intervention Type OTHER

Simultaneous MoCap and EMG acquisition

Eye-tracking acquisition for pathological subjects

Intervention Type OTHER

Eye-tracking acquisition for pathological subjects

Follow-up visit for pathological subjects

Intervention Type OTHER

Follow-up visit for pathological subjects

healthy volunteers

Group Type ACTIVE_COMPARATOR

dental impressions

Intervention Type OTHER

dental impressions

Simultaneous MoCap and EMG acquisition

Intervention Type OTHER

Simultaneous MoCap and EMG acquisition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dental impressions

dental impressions

Intervention Type OTHER

Simultaneous MoCap and EMG acquisition

Simultaneous MoCap and EMG acquisition

Intervention Type OTHER

Eye-tracking acquisition for pathological subjects

Eye-tracking acquisition for pathological subjects

Intervention Type OTHER

Follow-up visit for pathological subjects

Follow-up visit for pathological subjects

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with no known facial pathology (healthy volunteers) OR
* Patients with peripheral facial palsy, irrespective of grade, whether or not previously treated
* Subject with written informed consent
* Subject over 18 years of age
* Subject affiliated to a social security scheme

Exclusion Criteria

* Subjects with severe skin disorders that do not allow the application of electrodes or photo reflective markers
* Subjects with speech disorders making it impossible to pronounce the sounds \[o\] and \[pu\]
* Subject unable to provide written informed consent
* Subjects under guardianship, curators or safeguard of justice
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens Picardie

Amiens, Picardie, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stéphanie Dakpé, Pr

Role: CONTACT

03 22 08 90 50

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stéphanie DAKPE, Dr

Role: primary

+33322668322

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2021_843_0207

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neural Correlates of Intern Speech
NCT02830100 TERMINATED NA